
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9524210
[patent_doc_number] => 08748476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Darifenacin for use in the treatment of urgency induced by overactive bladder'
[patent_app_type] => utility
[patent_app_number] => 12/397433
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1578
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12397433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/397433 | Darifenacin for use in the treatment of urgency induced by overactive bladder | Mar 3, 2009 | Issued |
Array
(
[id] => 8394313
[patent_doc_number] => 20120232158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'METHODS OF TREATING HYPERACIDIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/919440
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14555
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919440 | METHODS OF TREATING HYPERACIDIC DISORDERS | Mar 2, 2009 | Abandoned |
Array
(
[id] => 5969314
[patent_doc_number] => 20110151001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION CONTAINING PROCHLORPERAZINE'
[patent_app_type] => utility
[patent_app_number] => 12/991134
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5610
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20110151001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991134
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991134 | PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION CONTAINING PROCHLORPERAZINE | Mar 2, 2009 | Abandoned |
Array
(
[id] => 6150035
[patent_doc_number] => 20110021630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'METHOD FOR TREATING WOUNDS BY ADMINISTERING FULLERENES'
[patent_app_type] => utility
[patent_app_number] => 12/921143
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9206
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021630.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921143 | METHOD FOR TREATING WOUNDS BY ADMINISTERING FULLERENES | Mar 2, 2009 | Abandoned |
Array
(
[id] => 5502767
[patent_doc_number] => 20090163455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'AVERMECTIN/HYDROCORTISONE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA'
[patent_app_type] => utility
[patent_app_number] => 12/394217
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2430
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163455.pdf
[firstpage_image] =>[orig_patent_app_number] => 12394217
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394217 | AVERMECTIN/HYDROCORTISONE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5502880
[patent_doc_number] => 20090163568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA'
[patent_app_type] => utility
[patent_app_number] => 12/394234
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2353
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163568.pdf
[firstpage_image] =>[orig_patent_app_number] => 12394234
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394234 | AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6097987
[patent_doc_number] => 20110003857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'STABILIZED, ANTIMICROBIALLY EFFECTIVE COMPOSITION WITH A CONTENT OF BISPYRIDINIUM ALKANE'
[patent_app_type] => utility
[patent_app_number] => 12/919523
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4684
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919523 | Stabilized, antimicrobially effective composition with a content of bispyridinium alkane | Feb 17, 2009 | Issued |
Array
(
[id] => 6007105
[patent_doc_number] => 20110059136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Methods and Compositions for Treating Inflammatory Bowel Disease'
[patent_app_type] => utility
[patent_app_number] => 12/918310
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9714
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059136.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918310 | Methods and compositions for treating inflammatory bowel disease | Feb 4, 2009 | Issued |
Array
(
[id] => 6026441
[patent_doc_number] => 20110054001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'CHK1 SUPPRESSES A CASPASE-2 APOPTOTIC RESPONSE TO DNA DAMAGE THAT BYPASSES P53, BCL-2 AND CASPASE-3'
[patent_app_type] => utility
[patent_app_number] => 12/866133
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 26897
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866133
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866133 | Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, bcl-2 and caspase-3 | Feb 3, 2009 | Issued |
Array
(
[id] => 5480648
[patent_doc_number] => 20090203605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Methods For Treating A Condition Characterized By Dysfunction In Protein Homeostasis'
[patent_app_type] => utility
[patent_app_number] => 12/364441
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 44277
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203605.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364441 | Methods For Treating A Condition Characterized By Dysfunction In Protein Homeostasis | Feb 1, 2009 | Abandoned |
Array
(
[id] => 8429620
[patent_doc_number] => 20120251495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'PTERIN BASED THERAPIES FOR INFLAMMATORY CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/384583
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 17390
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384583
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/384583 | PTERIN BASED THERAPIES FOR INFLAMMATORY CONDITIONS | Jan 15, 2009 | Abandoned |
Array
(
[id] => 10593453
[patent_doc_number] => 09314524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Topical formulations of Flucytosine'
[patent_app_type] => utility
[patent_app_number] => 12/342518
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8367
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12342518
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/342518 | Topical formulations of Flucytosine | Dec 22, 2008 | Issued |
Array
(
[id] => 8738405
[patent_doc_number] => 08410175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'Anticancer effect enhancer'
[patent_app_type] => utility
[patent_app_number] => 12/318061
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6218
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12318061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/318061 | Anticancer effect enhancer | Dec 21, 2008 | Issued |
Array
(
[id] => 5502857
[patent_doc_number] => 20090163545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Method For Altering The Lifespan Of Eukaryotic Organisms'
[patent_app_type] => utility
[patent_app_number] => 12/341615
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 8589
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163545.pdf
[firstpage_image] =>[orig_patent_app_number] => 12341615
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/341615 | Method for altering the lifespan of eukaryotic organisms | Dec 21, 2008 | Issued |
Array
(
[id] => 6002934
[patent_doc_number] => 20110118217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Agonists for Antimicrobial Peptide Systems'
[patent_app_type] => utility
[patent_app_number] => 12/811741
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17035
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811741
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811741 | Agonists for antimicrobial peptide systems | Dec 10, 2008 | Issued |
Array
(
[id] => 5441907
[patent_doc_number] => 20090093546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators'
[patent_app_type] => utility
[patent_app_number] => 12/274108
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6214
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12274108
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/274108 | Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators | Nov 18, 2008 | Abandoned |
Array
(
[id] => 5423091
[patent_doc_number] => 20090149547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'VIRUCIDAL DISINFECTANT FOR AVIAN INFLUENZA VIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/262371
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3299
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149547.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262371
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262371 | VIRUCIDAL DISINFECTANT FOR AVIAN INFLUENZA VIRUS | Oct 30, 2008 | Abandoned |
Array
(
[id] => 5265616
[patent_doc_number] => 20090118301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Compositions and Methods for Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/262023
[patent_app_country] => US
[patent_app_date] => 2008-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9326
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118301.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262023
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262023 | Compositions and Methods for Treating Cancer | Oct 29, 2008 | Abandoned |
Array
(
[id] => 5546660
[patent_doc_number] => 20090156537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/257852
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28640
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12257852
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/257852 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES | Oct 23, 2008 | Abandoned |
Array
(
[id] => 6617210
[patent_doc_number] => 20100099758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Regenerative wound healing using copper-silver citrate composition'
[patent_app_type] => utility
[patent_app_number] => 12/288749
[patent_app_country] => US
[patent_app_date] => 2008-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3435
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099758.pdf
[firstpage_image] =>[orig_patent_app_number] => 12288749
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288749 | Regenerative wound healing using copper-silver citrate composition | Oct 21, 2008 | Abandoned |